Welcome to the e-CCO Library!

search
Search by: 
Year: Category:
OP001: A phase III randomised controlled trial of Cx601, expanded allogeneic adipose-derived mesenchymal stem cells (eASC), for complex perianal fistulas in Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. Panés*1, D. García-Olmo2, G. Van Assche3, J. F. Colombel4, W. Reinisch5, D. C. Baumgart6, M. Nachury7, M. Ferrante3, L. Kazemi-Shirazi5, J. C. Grimaud8, F. de la Portilla9, E. Goldin10, A. Leselbaum11, M. C. Diez11, S. Danese12

Created: Friday, 22 February 2019, 9:49 AM
OP001: Gut barrier dysfunction: a primary defect in twins with Crohn’s disease predominantly caused by genetic predisposition
Year: 2018
Source: ECCO '18 Vienna
Authors:

Å.V. Keita1, C.M. Lindqvist2, Å. Öst3, C.D.L. Magana1, I. Schoultz2, J. Halfvarson4*

Created: Thursday, 21 February 2019, 9:14 AM
OP001: Whole genome sequencing and imputation in inflammatory bowel disease identifies 26 novel loci and offers therapeutically-relevant mechanistic insights
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Moutsianas L.*1, De Lange K.1, Luo Y.1,2,3, Lee J.4, Jostins L.5, Lamb C.6, Kennedy N.7, Mansfield J.8, Parkes M.4, Barrett J.1, Anderson C.1 UK Inflammatory Bowel Disease Genetics Consortium, Various, United Kingdom

Created: Wednesday, 20 February 2019, 10:36 AM
OP001: Whole genome sequencing and imputation in Inflammatory Bowel Disease identifies 26 novel loci and offers therapeutically-relevant mechanistic insights
Year: 2017
Source: ECCO'17 Barcelona
Authors: Moutsianas L.
Last Modified: Wednesday, 15 March 2017, 11:02 AM by Vesna Babaja
Genetic factors, Genetics, immunology
Files: 1
OP002: Assessment of disease activity patterns during the first 10 years after diagnosis in a population-based Crohn’s disease cohort shows a quiescent disease course for a substantial proportion of the population
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Wintjens1,2*, F. Bergey3, E. Saccenti4, S. Jeuring1,2, M. Romberg-Camps5, L. Oostenbrug5, A. Masclee1,2, D. Jonkers1,2, V. Martins dos Santos3,4, M. Pierik1,2

Created: Thursday, 21 February 2019, 9:14 AM
OP002: Assessment of disease activity patterns during the first 10 years after diagnosis in a population-based Crohn’s Disease cohort shows a quiescent disease course for a substantial proportion of the population
Year: 2018
Source: ECCO'18 Vienna
Authors: Wintjens Dion
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
OP002: Epigenetic biomarkers to detect UC associated neoplasia: Results from phase I of the ENDCAP-C study
Year: 2017
Source: ECCO'17 Barcelona
Authors: Iqbal T.
Last Modified: Wednesday, 15 March 2017, 1:35 PM by ECCO Administrator
Ulcerative colitis, UC colorectal cancer surveillance, Genetics
Files: 1
OP002: Epigenetic biomarkers to detect ulcerative colitis-associated neoplasia: results from phase I of the ENDCAP-C study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Iqbal T.*1, Beggs A.1, Taniere P.2, Wallis Y.3, Mehta S.4, Magill L.4, Deeks J.4, Matthews G.1, Morton D.1 EndCAP-C Consortium

Created: Wednesday, 20 February 2019, 10:36 AM
OP002: Histopathological response and remission after dual topical application of the Toll-like receptor 9 agonist DIMS0150 in patients with moderate-to-severe ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

R. Atreya*1, A. Öst2, C. Admyre3, A. Karlsson3, T. Knittel3, J. Kowalski3, F. Scaldaferi4, M. Neurath1, C. Hawkey5

Created: Friday, 22 February 2019, 9:49 AM
OP003: Increased risk of acute arterial events in young patients with severely active Inflammatory Bowel Disease: A nationwide French cohort study
Year: 2017
Source: ECCO'17 Barcelona
Authors: Kirchgesner J.
Last Modified: Wednesday, 15 March 2017, 1:43 PM by ECCO Administrator
Thromboembolism, Other extraintestinal manifestations
Files: 1
OP003: Increased risk of acute arterial events in young patients with severely active inflammatory bowel disease: a nationwide French cohort study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kirchgesner J.*1,2, Beaugerie L.1, Carrat F.3,4, Nyboe Andersen N.5, Jess T.5,6, Schwarzinger M.7,8 For the BERENICE Study Group

Created: Wednesday, 20 February 2019, 10:36 AM
OP003: Predicting short and medium-term efficacy of the biosimilar infliximab: trough levels/do anti-drug antibody’s or clinical/biochemical markers play a more important role?
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. A. Golovics*1, Z. Vegh1, M. Rutka2, K. Gecse1, A. Balint2, K. Farkas2, J. Banai3, L. Bene4, B. Gasztonyi5, T. Kristof6, L. Lakatos7, P. Miheller8, K. Palatka9, A. Patai10, A. Salamon11, T. Szamosi3, Z. Szepes12, G.T. Toth13, A. Vincze14, E. Biro15, B. Lovasz1, Z. Kurti1, F. Nagy12, T. Molnar2, P. Lakatos1

Created: Friday, 22 February 2019, 9:49 AM
OP003: Temporal changes in immune pathways with consecutive biological therapies as measured by serum proteomics
Year: 2018
Source: ECCO'18 Vienna
Authors: de Bruyn Magali
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
OP003: Temporal changes in immune pathways with consecutive biological therapies as measured by serum proteomics
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. de Bruyn1,2*, V. Ballet3, S. Verstockt4, B. Verstockt1,3, G. Van Assche1,3, M. Ferrante1,3, K. Machiels1, S. Vermeire1,3

Created: Thursday, 21 February 2019, 9:14 AM
OP004: Gene expression profiling indicates similar molecular pathways are active in adult and paediatric Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

A. Stojmirovic*, R. Dobrin, R. Strauss, D. Chan, K. Li, J. Friedman

Created: Friday, 22 February 2019, 9:49 AM
OP004: Resetting of the mucosal T cell repertoire after hematopoietic stem cell transplantation in refractory Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Le Bourhis L.1, Corraliza A.2, Auzolle C.1, Ricart E.2, Hawkey C.3, Lindsay J.O.4, Clark M.3, Rogler G.5, Satsangui J.6, Haller D.7, Panes J.2, Salas A.2, Allez M.*1

Created: Wednesday, 20 February 2019, 10:36 AM
OP004: Resetting of the mucosal T cell repertoire after hematopoietic stem cell transplantation in refractory Crohn‘s Disease
Year: 2017
Source: ECCO'17 Barcelona
Authors: Allez M.
Last Modified: Wednesday, 15 March 2017, 1:48 PM by ECCO Administrator
Autologous stem cell transplantation, T cell
Files: 1
OP004: The TLR9 agonist cobitolimod induces anti-inflammatory effects and balances the Th17/T-reg cell response in Ulcerative Colitis
Year: 2018
Source: ECCO'18 Vienna
Authors: García-Olmo, Damian
Created: Friday, 9 November 2018, 10:21 AM by Lindley Fritze
Ulcerative colitis , Genetics , Lymphocyte, T cell
OP004: The TLR9 agonist cobitolimod induces anti-inflammatory effects and balances the Th17/T-reg cell response in ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

H. Schmitt1*, U. Billmeier1, J. Ulmschneider1, C. Admyre2, T. Knittel2, A. Zargari2, M.F. Neurath1, R. Atreya1

Created: Thursday, 21 February 2019, 9:14 AM
OP005: A variable number of tandem repeat polymorphism in the promotor region of the neonatal Fc receptor affects anti-tumour necrosis factor serum levels in inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

T. Billiet*1, I. Cleynen1, M. Ferrante2, G. Van Assche2, A. Gils3, S. Vermeire2

Created: Friday, 22 February 2019, 9:49 AM